“Interleukin-enhancer binding factor 2 expression associates with chemotherapy response in triple-negative breast cancer

Authors

MA Bustos, ProvidenceFollow
X Zhang
DSB Hoon, ProvidenceFollow

Document Type

Presentation

Publication Date

12-1-2019

Clinical Institute

Cancer

Department

Oncology

Comments

” San Antonio Breast Cancer Symposium, December 2019 San Antonio, TX, USA; P6-03-11

Recommended Citation

Bustos, MA; Zhang, X; and Hoon, DSB, "“Interleukin-enhancer binding factor 2 expression associates with chemotherapy response in triple-negative breast cancer" (2019). Articles, Abstracts, and Reports. 7645.
https://digitalcommons.providence.org/publications/7645